Pylopass is a patented strain of Lactobacillus reuteri that offers a new approach to the control of Helicobacter pylori:
primary risk factor for ulcers and gastritis.
Pylopass has a unique mode of action;
Lactobacillus reuteri coaggregates specifically with Helicobacter pylori and so reduces its bacterial load in the stomach.
Pylopass also contains zinc, which contributes to:
- The normal acid-base metabolism.
- The normal function of the immune system.
- Normal carbohydrate metabolism and metabolism of fatty acids.
Pylopass is clinicaly proven to treat H.
Pylori.